Advertisement FDA approves CytoCore's cervical cell collector - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA approves CytoCore’s cervical cell collector

CytoCore has announced that the FDA has approved the company's 510(k) submission to sell CytoCore's SoftPAP cervical cell collector. The SoftPAP collects more comprehensive and complete cervical cell specimens for Pap testing.

Dan McMahon, director of marketing, CytoCore, said: “We are in the final stages of completing the North American distribution organization and expect to be able to launch the product in the US by the end of the first quarter.”